Fathi Amirhossein, Rismanchian Mansour, Dezaki Sara Nasrollahi
Dental Materials Research Center, Dental Prosthodontics Department, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Dental Implants Research Center, Dental Prosthodontics Department, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Eur J Dent. 2023 May;17(2):524-529. doi: 10.1055/s-0042-1747954. Epub 2022 Jul 12.
Opening of a healing abutment in two-stage implant systems is usually followed by a bad smell. Previous studies have found that presence of bacteria in microleakages of the implant-abutment interface results in further malodor. However, studies focusing on preventive treatments for this issue are scarce. Therefore, the aim of this study is to evaluate the effectiveness of two antimicrobial agents on prevention of malodor followed by opening the healing abutments.
Current double-blinded randomized clinical trial was performed on 51 eligible patients who were referred for their exposure surgery. They were divided equally into three parallel groups. In two groups, either chlorhexidine or tetracycline was added to the internal surface of the fixtures before screwing the healing abutments. One group did not receive any intervention. Three to 4 weeks later malodor was scored by sniffing the healing abutments immediately after uncovering them (odorless = 0/odor = 1). The three groups were then compared regarding malodor scores.
Our findings showed that malodor was more frequent in the control group (58.82%) in comparison with groups of intervention (17.65 and 23.53%). There was a statistically significant difference between malodor in patients in whom antimicrobial agents (chlorhexidine and tetracycline) were used in their implants and the control group (-value = 0.023). However, malodor in the chlorhexidine group and tetracycline group did not show any significant difference (-value = 1).
Based upon the data from this study, it appears that local antimicrobial agents including chlorhexidine and tetracycline result in less malodor production within the implant-abutment interface.
A specific type of malodor is commonly seen after opening the healing abutment of a two-stage dental implant. Not only this issue is noticed by the dentist, but also annoyed the patient. Using local antimicrobial agents in the fixtures is likely to be a simple, easily applicable solution that satisfies both patients and dentists, and eliminates the possibility of further inflammation.
在两段式种植系统中打开愈合基台后通常会出现异味。先前的研究发现,种植体-基台界面微渗漏中存在细菌会导致进一步的恶臭。然而,针对该问题的预防性治疗研究很少。因此,本研究的目的是评估两种抗菌剂在打开愈合基台后预防恶臭的有效性。
对51名因暴露手术前来就诊的符合条件的患者进行了当前的双盲随机临床试验。他们被平均分为三个平行组。在两组中,在拧上愈合基台之前,将洗必泰或四环素添加到种植体的内表面。一组未接受任何干预。三到四周后,在揭开愈合基台后立即通过嗅闻来对异味进行评分(无味=0/有异味=1)。然后比较三组的异味评分。
我们的研究结果表明,与干预组(17.65%和23.53%)相比,对照组中出现异味的情况更频繁(58.82%)。在种植体中使用抗菌剂(洗必泰或四环素)的患者与对照组之间的异味存在统计学上的显著差异(P值=0.023)。然而,洗必泰组和四环素组之间的异味没有显示出任何显著差异(P值=1)。
根据本研究的数据,似乎包括洗必泰和四环素在内的局部抗菌剂可减少种植体-基台界面内的恶臭产生。
在打开两段式牙种植体的愈合基台后,通常会出现一种特定类型的恶臭。这个问题不仅会被牙医注意到,也会让患者感到烦恼。在种植体中使用局部抗菌剂可能是一种简单、易于应用的解决方案,既能让患者和牙医都满意,又能消除进一步炎症的可能性。